Kumar Neil 的 Form 4 申報
BridgeBio Pharma, Inc.（BBIO），2025/12/8 申報
- 申報編號
- 0001470831-25-000386
- 申報時間
- 2025/12/8
- 交易日
- 2025/12/4-12/5
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $590.8 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kumar NeilCIK 0001742485 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/12/4 | Common Stock | S賣出處分 | −2,100 | $73.16F2 | −$153,636 | 793,586 | 間接 | |
| 2025/12/4 | Common Stock | S賣出處分 | −12,192 | $74.42F4 | −$907,328.64 | 781,394 | 間接 | |
| 2025/12/4 | Common Stock | S賣出處分 | −5,708 | $74.80F5 | −$426,958.4 | 775,686 | 間接 | |
| 2025/12/5 | Common Stock | S賣出處分 | −12,517 | $73.05F6 | −$914,366.85 | 763,169 | 間接 | |
| 2025/12/5 | Common Stock | S賣出處分 | −7,483 | $73.76F7 | −$551,946.08 | 755,686 | 間接 | |
| 2025/12/4 | Common Stock | S賣出處分 | −2,100 | $73.16F8 | −$153,636 | 4,596,347 | 間接 | |
| 2025/12/4 | Common Stock | S賣出處分 | −12,200 | $74.42F4 | −$907,924 | 4,584,147 | 間接 | |
| 2025/12/4 | Common Stock | S賣出處分 | −5,700 | $74.80F5 | −$426,360 | 4,578,447 | 間接 | |
| 2025/12/5 | Common Stock | S賣出處分 | −12,288 | $73.04F9 | −$897,515.52 | 4,566,159 | 間接 | |
| 2025/12/5 | Common Stock | S賣出處分 | −7,712 | $73.75F10 | −$568,760 | 4,558,447 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average sale price of the shares sold from $72.71 to $73.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of the shares sold from $73.73 to $74.72 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F5
Represents the weighted average sale price of the shares sold from $74.73 to $74.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of the shares sold from $72.46 to $73.45 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents the weighted average sale price of the shares sold from $73.46 to $74.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents the weighted average sale price of the shares sold from $72.71 to $73.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents the weighted average sale price of the shares sold from $72.41 to $73.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents the weighted average sale price of the shares sold from $73.42 to $74.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。